Literature DB >> 28474358

E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol.

Qingchun Chen1, Lin Wang1, Minghu Jiang2, Juxiang Huang1, Zhenfu Jiang1, Haitao Feng3, Zhili Ji4.   

Abstract

Breast cancer 1 (BRCA1) and E2F transcription factor 1 (E2F1) are related to metabolism and cell cycle regulation. However, the corresponding mechanism is not clear in HCC. High BRCA1 direct pathway was constructed with 11 molecules from E2F1 feedback-interactive network in HCC by GRNInfer based on 39 Pearson mutual positive corelation CC ≥0.25 molecules with E2F1. Integration of GRNInfer with GO, KEGG, BioCarta, GNF_U133A, UNIGENE_EST, Disease, GenMAPP databases by DAVID and MAS 3.0, E2F1 feedback-interactive BRCA1 indirect mitochondrion to cytosol pathway was identified as upstream LAPTM4B activation, feedback UNG, downstream BCAT1-HIST1H2AD-TK1 reflecting protein, and DNA binding with enrichment of small molecule metabolism; The corresponding BRCA1 indirect membrane to cytosol pathway as upstream CCNB2-NUSAP1 activation, feedback TTK-HIST1H2BJ-CENPF, downstream MCM4-TK1 reflecting ATP, and microtubule binding with enrichment of CD4+T-related cell cycle regulation in HCC. Therefore, we propose that E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol. Knowledge analysis demonstrates our E2F1 feedback-interactive BRCA1 pathway wide disease distribution and reflects a novel common one of tumor and cancer.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CD4+T-related cell cycle regulation; HCC; from mitochondrion or membrane to cytosol; high E2F1 feedback-interactive BRCA1 pathway; small molecule metabolism

Mesh:

Substances:

Year:  2017        PMID: 28474358     DOI: 10.1002/jcp.25988

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.

Authors:  Kai Chen; Yifu Hou; Rui Liao; Youzan Li; Hongji Yang; Jun Gong
Journal:  Oncogene       Date:  2021-04-06       Impact factor: 9.867

2.  Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.

Authors:  Yan-Lin Huang; Gang Ning; Lu-Biao Chen; Yi-Fan Lian; Yu-Rong Gu; Jia-Liang Wang; Dong-Mei Chen; Huan Wei; Yue-Hua Huang
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

3.  Identify and Validate the Transcriptomic, Functional Network, and Predictive Validity of FBXL19-AS1 in Hepatocellular Carcinoma.

Authors:  Dingdong He; Xiaokang Zhang; Xinyu Zhu; Narayani Maharjan; Yingchao Wang; Ping Luo; Chunzi Liang; Jiancheng Tu
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

4.  Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma.

Authors:  Yugang Huang; Xiuwen Chen; Li Wang; Tieyan Wang; Xianbin Tang; Xiaomin Su
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

5.  CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.

Authors:  Yu-Gang Huang; Dan Li; Li Wang; Xiao-Min Su; Xian-Bin Tang
Journal:  J Transl Med       Date:  2022-02-05       Impact factor: 5.531

6.  CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma.

Authors:  Mengzhi Li; Jingling Zhao; Ronghua Yang; Ruizhao Cai; Xusheng Liu; Julin Xie; Bin Shu; Shaohai Qi
Journal:  Cancer Sci       Date:  2022-03-01       Impact factor: 6.716

7.  E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma.

Authors:  Zhibo Tan; Min Chen; Feng Peng; Pengfei Yang; Zhaoming Peng; Zhe Zhang; Xin Li; Xiaopeng Zhu; Lei Zhang; Yujie Zhao; Yajie Liu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

8.  Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma.

Authors:  Wenlei Dong; Chao Zhan
Journal:  J Gastrointest Oncol       Date:  2022-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.